Introduction
The lead seat in a continuation vehicle (CV) has become valuable enough to share. Morgan Lewis, reviewing the 169 continuation vehicles its lawyers advised between early 2021 and early 2026, reported in May 2026 that competition for lead positions was intensifying and that co-lead structures were becoming more common. The lead investor prices the assets, negotiates the new fund's terms, and usually writes the largest check, and every syndicate investor and rolling limited partner (LP) then takes a deal the lead shaped. For the private capital advisory (PCA) banker advising the general partner (GP), recommending a lead means choosing whose judgment, economics, and GP relationship everyone else in the vehicle will live with.
What Makes a Buyer Lead-Capable
Most secondary buyers can join a CV; far fewer can lead one. An advisor sizing the lead-capable pool tests each name on five traits:
- Capacity. In Houlihan Lokey's 2025 continuation fund study, 56% of sampled deals had lead checks above $250 million.
- Company-level underwriting. William Blair found "market-tested" pricing, informed by an earlier M&A process, in only 11% of 2025 continuation fund volume, so leads rely on their own work.
- Speed and certainty. A firm commitment beats a slightly higher bid with conditions.
- Standing. A limited partner advisory committee (LPAC) reads a known lead's price as evidence.
- Ability to hold size within the buyer's own concentration limits for the life of the vehicle.
Which kinds of buyer lead which deals is covered in continuation vehicles explained, and their decision criteria in how buyers assess a continuation vehicle.
What the Lead Negotiates
Winning the bid starts the second half of the job. The lead prices the assets and the GP's go-forward deal as a single package, because price and alignment trade off against each other.
- Lead Investor (Continuation Vehicle)
The secondary buyer, or small group of buyers, chosen through the GP's process to set the price of the transferred assets and negotiate the terms of the continuation vehicle, usually with the largest new commitment. Other new investors typically join at its price and on substantially its terms.
Price, Fund Terms, and Governance
The package covers the price against reference-date net asset value (NAV), the CV's management fee and tiered carry, the GP's rollover and fresh commitment, the term, and protections such as key person provisions, present in 64% of the CVs Morgan Lewis reviewed. New investors acquire largely passive LP interests, but the lead can gain more influence and sometimes a seat on the CV's own advisory committee, which will review the GP's later conflicts.
Allocation Rights and the Shortfall
Leads often condition their commitment on a minimum allocation with priority over other new investors and sometimes over rolling LPs. Some GPs grant the lead a right of first refusal on any funding shortfall, while a few leads ask for the opposite, a cap that stops the GP over-allocating to them. Some active leads also win the right to place part of the vehicle with their own clients, a practice Jefferies' January 2025 market review linked to LP demand for co-investment in secondaries.
| Term | What the lead negotiates | Where syndicate investors stand |
|---|---|---|
| Price | Percentage of NAV, any deferral | Same price |
| Fees and carry | Rate, base, and tiers for the vehicle | Same, unless a size-based discount applies |
| Legal and formation costs | Its legal costs reimbursed up to a cap | Share formation costs |
| Governance | Possible advisory committee seat | Usually passive |
| Allocation | Minimum ticket, shortfall rights, placement with own clients | Allocated by the GP from what remains |
Co-Leads and Club Structures
A co-lead structure splits the seat between buyers who negotiate together and share the anchor position. Tickets on larger deals can exceed one buyer's limits, the GP gains a second underwriting and more certainty that the book fills, and buyers facing competition would rather share the seat than lose it. The cost is a negotiation among co-leads before the one with the GP. Below the co-leads, Jefferies' January 2025 review saw smaller would-be leads settle for anchor syndicate positions. The arrangement resembles a sponsor club deal or consortium, except that the co-leads are buying from the manager they will then back, as BU Bregal Unternehmerkapital's July 2026 announcement shows.
Preferred Lead Economics and the Syndicate's View
How often leads receive preferred terms, and in what forms, is summarized in CV economics, which cites William Blair's 41% figure for 2025. The advisor's sharper question is who pays for each preference.
What Preferred Terms Cost Other Investors
A fee or carry discount on the lead's commitment is paid by the GP through lower revenue, not by other investors. GCM Grosvenor, which invests in CVs alongside lead and co-lead buyers, calls these discounts generally moderate and driven more by check size than by lead status, the logic of the size-tiered most favored nation (MFN) rights explained in the limited partnership agreement article.
Cost exclusions are different, because they shift a shared cost onto others. The Institutional Limited Partners Association's (ILPA) June 2026 draft guidance, whose comment period closed on August 5, 2026, describes formation costs borne by CV investors, including rollers but not the lead, under a cap converging around 0.75% to 1%. On an illustrative $600 million vehicle with $4.5 million of formation costs, sharing puts 0.75% on every investor; excluding the lead's $250 million puts about 1.29% on the other $350 million.
Why a Smaller Investor Joins on Another's Diligence
The syndicate's bargain is access without competing for the seat. GCM reports that syndicate investors buy at the lead's price and on largely the same terms, with data rooms that include quality of earnings reports, valuation reports, and projections.
- Syndicate Investor (Continuation Vehicle)
A new investor that commits to a continuation vehicle after the lead investor has set the price and terms, joining at that price and on substantially the same terms, usually with a smaller commitment and without negotiating the documents.
Without influence over the price, a careful syndicate investor checks:
- how much of the headline ticket the lead will hold itself;
- whether a link to a future fund commitment bought the lead a lower price;
- the size and source of the GP's commitment;
- the plan assumptions that separate the price from a discount.
As with cornerstone investors in an IPO, the rest of the book reads the lead as a signal.
Where Relying on One Lead Breaks Down
The model concentrates judgment in one buyer, and three risks follow. With syndicates thinning on smaller deals, a trend covered in the advisor's side of syndication, the price rests on one model. The second is a lead that wants out: one that walks after the LPAC briefing can collapse the timetable, and after closing its stake transfers only with the GP's consent, taking with it the seat and record that reassured others.
The third is the relationship bid. William Blair's 2026 secondary market report found that about 49% of US investors and 43% of European investors committed primary capital to the sponsor's successor flagship fund after a continuation fund closed, while explicit stapled commitments featured in only 3% of deals. GCM adds that being an existing investor in a sponsor's funds counts as much as lead status in winning allocations on oversubscribed deals.
When the link is explicit, stapled secondaries show how buyers weigh the combined economics; when implicit, the defense is disclosure and comparing every final bid on price, terms, and conditions.
The lead's influence outlasts the auction. Its seat, its stake, and its standing with the GP carry into every later decision, from follow-on funding to the exit and perhaps a second continuation vehicle. Selling LPs never meet the lead; rolling LPs live with it for years, which is why price is only the first line of the comparison between leads.
